ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,281, issued on March 25, was assigned to Seagen Inc. (Bothell, Wash.).
"Hydrophilic antibody-drug conjugates" was invented by Svetlana Doronina (Snohomish, Wash.), Robert Lyon (Sammamish, Wash.) and Peter Senter (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "Hydrophilic Linkers, Drug-Linker compounds, Drug-Ligand Conjugate compounds and Ligand-Linkers and methods of making and using the same are provided."
The patent was filed on July 28, 2023, under Application No. 18/361,558.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2...